img

Global Recombinant Therapeutic Protein Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Recombinant Therapeutic Protein Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Recombinant Therapeutic Protein are produced by using a technique called recombinant DNA or recombinant RNA to produce proteins. The method can be divided into in vitro method and in vivo method. Both approaches are premised on the use of genetic recombination techniques to obtain recombinant vectors attached to gene fragments that can be translated into target proteins and then transferred to host cells that can express target proteins to express specific recombinant governance protein molecules.
Recombinant Therapeutic Protein report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Recombinant Therapeutic Protein market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Medicine and Scientific Research are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Recombinant Therapeutic Protein industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Recombinant Therapeutic Protein key manufacturers include Boehringer Ingelheim, Bristol-Myers Squibb, Celldex Therapeutics, Eli Liily, GlaxoSmithKline, Merck, Novartis, Regeneron Pharmaceuticals and Roche, etc. Boehringer Ingelheim, Bristol-Myers Squibb, Celldex Therapeutics are top 3 players and held % sales share in total in 2022.
Recombinant Therapeutic Protein can be divided into Recombinant Human Collage and Recombinant Human Serum Albumin, etc. Recombinant Human Collage is the mainstream product in the market, accounting for % sales share globally in 2022.
Recombinant Therapeutic Protein is widely used in various fields, such as Medicine, Scientific Research and Others,, etc. Medicine provides greatest supports to the Recombinant Therapeutic Protein industry development. In 2022, global % sales of Recombinant Therapeutic Protein went into Medicine filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Recombinant Therapeutic Protein market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Boehringer Ingelheim
Bristol-Myers Squibb
Celldex Therapeutics
Eli Liily
GlaxoSmithKline
Merck
Novartis
Regeneron Pharmaceuticals
Roche
Takeda
Segment by Type
Recombinant Human Collage
Recombinant Human Serum Albumin

Segment by Application


Medicine
Scientific Research
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Recombinant Therapeutic Protein market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Recombinant Therapeutic Protein, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Recombinant Therapeutic Protein industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Recombinant Therapeutic Protein in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Recombinant Therapeutic Protein introduction, etc. Recombinant Therapeutic Protein Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Recombinant Therapeutic Protein market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Recombinant Therapeutic Protein Market Overview
1.1 Recombinant Therapeutic Protein Product Overview
1.2 Recombinant Therapeutic Protein Market Segment by Type
1.2.1 Recombinant Human Collage
1.2.2 Recombinant Human Serum Albumin
1.3 Global Recombinant Therapeutic Protein Market Size by Type
1.3.1 Global Recombinant Therapeutic Protein Market Size Overview by Type (2018-2034)
1.3.2 Global Recombinant Therapeutic Protein Historic Market Size Review by Type (2018-2024)
1.3.3 Global Recombinant Therapeutic Protein Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Recombinant Therapeutic Protein Sales Breakdown by Type (2018-2024)
1.4.2 Europe Recombinant Therapeutic Protein Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Recombinant Therapeutic Protein Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Recombinant Therapeutic Protein Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Recombinant Therapeutic Protein Sales Breakdown by Type (2018-2024)
2 Global Recombinant Therapeutic Protein Market Competition by Company
2.1 Global Top Players by Recombinant Therapeutic Protein Sales (2018-2024)
2.2 Global Top Players by Recombinant Therapeutic Protein Revenue (2018-2024)
2.3 Global Top Players by Recombinant Therapeutic Protein Price (2018-2024)
2.4 Global Top Manufacturers Recombinant Therapeutic Protein Manufacturing Base Distribution, Sales Area, Product Type
2.5 Recombinant Therapeutic Protein Market Competitive Situation and Trends
2.5.1 Recombinant Therapeutic Protein Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Recombinant Therapeutic Protein Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Therapeutic Protein as of 2022)
2.7 Date of Key Manufacturers Enter into Recombinant Therapeutic Protein Market
2.8 Key Manufacturers Recombinant Therapeutic Protein Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Recombinant Therapeutic Protein Status and Outlook by Region
3.1 Global Recombinant Therapeutic Protein Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Recombinant Therapeutic Protein Historic Market Size by Region
3.2.1 Global Recombinant Therapeutic Protein Sales in Volume by Region (2018-2024)
3.2.2 Global Recombinant Therapeutic Protein Sales in Value by Region (2018-2024)
3.2.3 Global Recombinant Therapeutic Protein Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Recombinant Therapeutic Protein Forecasted Market Size by Region
3.3.1 Global Recombinant Therapeutic Protein Sales in Volume by Region (2024-2034)
3.3.2 Global Recombinant Therapeutic Protein Sales in Value by Region (2024-2034)
3.3.3 Global Recombinant Therapeutic Protein Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Recombinant Therapeutic Protein by Application
4.1 Recombinant Therapeutic Protein Market Segment by Application
4.1.1 Medicine
4.1.2 Scientific Research
4.1.3 Others
4.2 Global Recombinant Therapeutic Protein Market Size by Application
4.2.1 Global Recombinant Therapeutic Protein Market Size Overview by Application (2018-2034)
4.2.2 Global Recombinant Therapeutic Protein Historic Market Size Review by Application (2018-2024)
4.2.3 Global Recombinant Therapeutic Protein Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Recombinant Therapeutic Protein Sales Breakdown by Application (2018-2024)
4.3.2 Europe Recombinant Therapeutic Protein Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Recombinant Therapeutic Protein Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Recombinant Therapeutic Protein Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Recombinant Therapeutic Protein Sales Breakdown by Application (2018-2024)
5 North America Recombinant Therapeutic Protein by Country
5.1 North America Recombinant Therapeutic Protein Historic Market Size by Country
5.1.1 North America Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Recombinant Therapeutic Protein Sales in Volume by Country (2018-2024)
5.1.3 North America Recombinant Therapeutic Protein Sales in Value by Country (2018-2024)
5.2 North America Recombinant Therapeutic Protein Forecasted Market Size by Country
5.2.1 North America Recombinant Therapeutic Protein Sales in Volume by Country (2024-2034)
5.2.2 North America Recombinant Therapeutic Protein Sales in Value by Country (2024-2034)
6 Europe Recombinant Therapeutic Protein by Country
6.1 Europe Recombinant Therapeutic Protein Historic Market Size by Country
6.1.1 Europe Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Recombinant Therapeutic Protein Sales in Volume by Country (2018-2024)
6.1.3 Europe Recombinant Therapeutic Protein Sales in Value by Country (2018-2024)
6.2 Europe Recombinant Therapeutic Protein Forecasted Market Size by Country
6.2.1 Europe Recombinant Therapeutic Protein Sales in Volume by Country (2024-2034)
6.2.2 Europe Recombinant Therapeutic Protein Sales in Value by Country (2024-2034)
7 Asia-Pacific Recombinant Therapeutic Protein by Region
7.1 Asia-Pacific Recombinant Therapeutic Protein Historic Market Size by Region
7.1.1 Asia-Pacific Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Recombinant Therapeutic Protein Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Recombinant Therapeutic Protein Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Recombinant Therapeutic Protein Forecasted Market Size by Region
7.2.1 Asia-Pacific Recombinant Therapeutic Protein Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Recombinant Therapeutic Protein Sales in Value by Region (2024-2034)
8 Latin America Recombinant Therapeutic Protein by Country
8.1 Latin America Recombinant Therapeutic Protein Historic Market Size by Country
8.1.1 Latin America Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Recombinant Therapeutic Protein Sales in Volume by Country (2018-2024)
8.1.3 Latin America Recombinant Therapeutic Protein Sales in Value by Country (2018-2024)
8.2 Latin America Recombinant Therapeutic Protein Forecasted Market Size by Country
8.2.1 Latin America Recombinant Therapeutic Protein Sales in Volume by Country (2024-2034)
8.2.2 Latin America Recombinant Therapeutic Protein Sales in Value by Country (2024-2034)
9 Middle East and Africa Recombinant Therapeutic Protein by Country
9.1 Middle East and Africa Recombinant Therapeutic Protein Historic Market Size by Country
9.1.1 Middle East and Africa Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Recombinant Therapeutic Protein Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Recombinant Therapeutic Protein Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Recombinant Therapeutic Protein Forecasted Market Size by Country
9.2.1 Middle East and Africa Recombinant Therapeutic Protein Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Recombinant Therapeutic Protein Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Company Information
10.1.2 Boehringer Ingelheim Introduction and Business Overview
10.1.3 Boehringer Ingelheim Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Boehringer Ingelheim Recombinant Therapeutic Protein Products Offered
10.1.5 Boehringer Ingelheim Recent Development
10.2 Bristol-Myers Squibb
10.2.1 Bristol-Myers Squibb Company Information
10.2.2 Bristol-Myers Squibb Introduction and Business Overview
10.2.3 Bristol-Myers Squibb Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bristol-Myers Squibb Recombinant Therapeutic Protein Products Offered
10.2.5 Bristol-Myers Squibb Recent Development
10.3 Celldex Therapeutics
10.3.1 Celldex Therapeutics Company Information
10.3.2 Celldex Therapeutics Introduction and Business Overview
10.3.3 Celldex Therapeutics Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Celldex Therapeutics Recombinant Therapeutic Protein Products Offered
10.3.5 Celldex Therapeutics Recent Development
10.4 Eli Liily
10.4.1 Eli Liily Company Information
10.4.2 Eli Liily Introduction and Business Overview
10.4.3 Eli Liily Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Eli Liily Recombinant Therapeutic Protein Products Offered
10.4.5 Eli Liily Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Information
10.5.2 GlaxoSmithKline Introduction and Business Overview
10.5.3 GlaxoSmithKline Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2018-2024)
10.5.4 GlaxoSmithKline Recombinant Therapeutic Protein Products Offered
10.5.5 GlaxoSmithKline Recent Development
10.6 Merck
10.6.1 Merck Company Information
10.6.2 Merck Introduction and Business Overview
10.6.3 Merck Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Merck Recombinant Therapeutic Protein Products Offered
10.6.5 Merck Recent Development
10.7 Novartis
10.7.1 Novartis Company Information
10.7.2 Novartis Introduction and Business Overview
10.7.3 Novartis Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Novartis Recombinant Therapeutic Protein Products Offered
10.7.5 Novartis Recent Development
10.8 Regeneron Pharmaceuticals
10.8.1 Regeneron Pharmaceuticals Company Information
10.8.2 Regeneron Pharmaceuticals Introduction and Business Overview
10.8.3 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Products Offered
10.8.5 Regeneron Pharmaceuticals Recent Development
10.9 Roche
10.9.1 Roche Company Information
10.9.2 Roche Introduction and Business Overview
10.9.3 Roche Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Roche Recombinant Therapeutic Protein Products Offered
10.9.5 Roche Recent Development
10.10 Takeda
10.10.1 Takeda Company Information
10.10.2 Takeda Introduction and Business Overview
10.10.3 Takeda Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Takeda Recombinant Therapeutic Protein Products Offered
10.10.5 Takeda Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Recombinant Therapeutic Protein Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Recombinant Therapeutic Protein Industrial Chain Analysis
11.4 Recombinant Therapeutic Protein Market Dynamics
11.4.1 Recombinant Therapeutic Protein Industry Trends
11.4.2 Recombinant Therapeutic Protein Market Drivers
11.4.3 Recombinant Therapeutic Protein Market Challenges
11.4.4 Recombinant Therapeutic Protein Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Recombinant Therapeutic Protein Distributors
12.3 Recombinant Therapeutic Protein Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Recombinant Human Collage
Table 2. Major Company of Recombinant Human Serum Albumin
Table 3. Global Recombinant Therapeutic Protein Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Recombinant Therapeutic Protein Sales by Type (2018-2024) & (MT)
Table 5. Global Recombinant Therapeutic Protein Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Recombinant Therapeutic Protein Sales by Type (2018-2024) & (US& Million)
Table 7. Global Recombinant Therapeutic Protein Market Share in Value by Type (2018-2024)
Table 8. Global Recombinant Therapeutic Protein Price by Type (2018-2024) & (USD/MT)
Table 9. Global Recombinant Therapeutic Protein Sales by Type (2024-2034) & (MT)
Table 10. Global Recombinant Therapeutic Protein Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Recombinant Therapeutic Protein Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Recombinant Therapeutic Protein Sales Market Share in Value by Type (2024-2034)
Table 13. Global Recombinant Therapeutic Protein Price by Type (2024-2034) & (USD/MT)
Table 14. North America Recombinant Therapeutic Protein Sales by Type (2018-2024) & (MT)
Table 15. North America Recombinant Therapeutic Protein Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Recombinant Therapeutic Protein Sales (MT) by Type (2018-2024)
Table 17. Europe Recombinant Therapeutic Protein Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Recombinant Therapeutic Protein Sales (MT) by Type (2018-2024)
Table 19. Asia-Pacific Recombinant Therapeutic Protein Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Recombinant Therapeutic Protein Sales (MT) by Type (2018-2024)
Table 21. Latin America Recombinant Therapeutic Protein Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Recombinant Therapeutic Protein Sales (MT) by Type (2018-2024)
Table 23. Middle East and Africa Recombinant Therapeutic Protein Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Recombinant Therapeutic Protein Sales by Company (2018-2024) & (MT)
Table 25. Global Recombinant Therapeutic Protein Sales Share by Company (2018-2024)
Table 26. Global Recombinant Therapeutic Protein Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Recombinant Therapeutic Protein Revenue Share by Company (2018-2024)
Table 28. Global Market Recombinant Therapeutic Protein Price by Company (2018-2024) & (USD/MT)
Table 29. Global Recombinant Therapeutic Protein Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Recombinant Therapeutic Protein Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Therapeutic Protein as of 2022)
Table 32. Date of Key Manufacturers Enter into Recombinant Therapeutic Protein Market
Table 33. Key Manufacturers Recombinant Therapeutic Protein Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Recombinant Therapeutic Protein Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Recombinant Therapeutic Protein Sales by Region (2018-2024) & (MT)
Table 37. Global Recombinant Therapeutic Protein Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Recombinant Therapeutic Protein Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Recombinant Therapeutic Protein Sales Market Share in Value by Region (2018-2024)
Table 40. Global Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 41. Global Recombinant Therapeutic Protein Sales by Region (2024-2034) & (MT)
Table 42. Global Recombinant Therapeutic Protein Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Recombinant Therapeutic Protein Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Recombinant Therapeutic Protein Sales Market Share in Value by Region (2024-2034)
Table 45. Global Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 46. Global Recombinant Therapeutic Protein Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Recombinant Therapeutic Protein Sales by Application (2018-2024) & (MT)
Table 48. Global Recombinant Therapeutic Protein Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Recombinant Therapeutic Protein Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Recombinant Therapeutic Protein Sales Market Share in Value by Application (2018-2024)
Table 51. Global Recombinant Therapeutic Protein Price by Application (2018-2024) & (USD/MT)
Table 52. Global Recombinant Therapeutic Protein Sales by Application (2024-2034) & (MT)
Table 53. Global Recombinant Therapeutic Protein Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Recombinant Therapeutic Protein Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Recombinant Therapeutic Protein Sales Market Share in Value by Application (2024-2034)
Table 56. Global Recombinant Therapeutic Protein Price by Application (2024-2034) & (USD/MT)
Table 57. North America Recombinant Therapeutic Protein Sales by Application (2018-2024) (MT)
Table 58. North America Recombinant Therapeutic Protein Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Recombinant Therapeutic Protein Sales by Application (2018-2024) (MT)
Table 60. Europe Recombinant Therapeutic Protein Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Recombinant Therapeutic Protein Sales by Application (2018-2024) (MT)
Table 62. Asia-Pacific Recombinant Therapeutic Protein Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Recombinant Therapeutic Protein Sales by Application (2018-2024) (MT)
Table 64. Latin America Recombinant Therapeutic Protein Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Recombinant Therapeutic Protein Sales by Application (2018-2024) (MT)
Table 66. Middle East and Africa Recombinant Therapeutic Protein Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Recombinant Therapeutic Protein Sales by Country (2018-2024) & (MT)
Table 68. North America Recombinant Therapeutic Protein Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Recombinant Therapeutic Protein Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Recombinant Therapeutic Protein Sales Market Share in Value by Country (2018-2024)
Table 71. North America Recombinant Therapeutic Protein Sales by Country (2024-2034) & (MT)
Table 72. North America Recombinant Therapeutic Protein Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Recombinant Therapeutic Protein Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Recombinant Therapeutic Protein Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Recombinant Therapeutic Protein Sales by Country (2018-2024) & (MT)
Table 76. Europe Recombinant Therapeutic Protein Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Recombinant Therapeutic Protein Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Recombinant Therapeutic Protein Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Recombinant Therapeutic Protein Sales by Country (2024-2034) & (MT)
Table 80. Europe Recombinant Therapeutic Protein Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Recombinant Therapeutic Protein Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Recombinant Therapeutic Protein Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Recombinant Therapeutic Protein Sales by Region (2018-2024) & (MT)
Table 84. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Recombinant Therapeutic Protein Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Recombinant Therapeutic Protein Sales by Region (2024-2034) & (MT)
Table 88. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Recombinant Therapeutic Protein Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Recombinant Therapeutic Protein Sales by Country (2018-2024) & (MT)
Table 92. Latin America Recombinant Therapeutic Protein Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Recombinant Therapeutic Protein Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Recombinant Therapeutic Protein Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Recombinant Therapeutic Protein Sales by Country (2024-2034) & (MT)
Table 96. Latin America Recombinant Therapeutic Protein Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Recombinant Therapeutic Protein Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Recombinant Therapeutic Protein Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2018-2024) & (MT)
Table 100. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2024-2034) & (MT)
Table 104. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share in Value by Country (2024-2034)
Table 107. Boehringer Ingelheim Company Information
Table 108. Boehringer Ingelheim Introduction and Business Overview
Table 109. Boehringer Ingelheim Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 110. Boehringer Ingelheim Recombinant Therapeutic Protein Product
Table 111. Boehringer Ingelheim Recent Development
Table 112. Bristol-Myers Squibb Company Information
Table 113. Bristol-Myers Squibb Introduction and Business Overview
Table 114. Bristol-Myers Squibb Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 115. Bristol-Myers Squibb Recombinant Therapeutic Protein Product
Table 116. Bristol-Myers Squibb Recent Development
Table 117. Celldex Therapeutics Company Information
Table 118. Celldex Therapeutics Introduction and Business Overview
Table 119. Celldex Therapeutics Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 120. Celldex Therapeutics Recombinant Therapeutic Protein Product
Table 121. Celldex Therapeutics Recent Development
Table 122. Eli Liily Company Information
Table 123. Eli Liily Introduction and Business Overview
Table 124. Eli Liily Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 125. Eli Liily Recombinant Therapeutic Protein Product
Table 126. Eli Liily Recent Development
Table 127. GlaxoSmithKline Company Information
Table 128. GlaxoSmithKline Introduction and Business Overview
Table 129. GlaxoSmithKline Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 130. GlaxoSmithKline Recombinant Therapeutic Protein Product
Table 131. GlaxoSmithKline Recent Development
Table 132. Merck Company Information
Table 133. Merck Introduction and Business Overview
Table 134. Merck Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 135. Merck Recombinant Therapeutic Protein Product
Table 136. Merck Recent Development
Table 137. Novartis Company Information
Table 138. Novartis Introduction and Business Overview
Table 139. Novartis Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 140. Novartis Recombinant Therapeutic Protein Product
Table 141. Novartis Recent Development
Table 142. Regeneron Pharmaceuticals Company Information
Table 143. Regeneron Pharmaceuticals Introduction and Business Overview
Table 144. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 145. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product
Table 146. Regeneron Pharmaceuticals Recent Development
Table 147. Roche Company Information
Table 148. Roche Introduction and Business Overview
Table 149. Roche Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 150. Roche Recombinant Therapeutic Protein Product
Table 151. Roche Recent Development
Table 152. Takeda Company Information
Table 153. Takeda Introduction and Business Overview
Table 154. Takeda Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 155. Takeda Recombinant Therapeutic Protein Product
Table 156. Takeda Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Recombinant Therapeutic Protein Market Trends
Table 160. Recombinant Therapeutic Protein Market Drivers
Table 161. Recombinant Therapeutic Protein Market Challenges
Table 162. Recombinant Therapeutic Protein Market Restraints
Table 163. Recombinant Therapeutic Protein Distributors List
Table 164. Recombinant Therapeutic Protein Downstream Customers
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Therapeutic Protein Product Picture
Figure 2. Global Recombinant Therapeutic Protein Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Recombinant Therapeutic Protein Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Recombinant Therapeutic Protein Sales Status and Outlook (2018-2034) & (MT)
Figure 5. Product Picture of Recombinant Human Collage
Figure 6. Global Recombinant Human Collage Sales YoY Growth (2018-2034) & (MT)
Figure 7. Product Picture of Recombinant Human Serum Albumin
Figure 8. Global Recombinant Human Serum Albumin Sales YoY Growth (2018-2034) & (MT)
Figure 9. Global Recombinant Therapeutic Protein Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Recombinant Therapeutic Protein Sales Market Share by Type in 2022 & 2034
Figure 11. North America Recombinant Therapeutic Protein Sales Market Share in Volume by Type in 2022
Figure 12. North America Recombinant Therapeutic Protein Sales Market Share in Value by Type in 2022
Figure 13. Europe Recombinant Therapeutic Protein Sales Market Share in Volume by Type in 2022
Figure 14. Europe Recombinant Therapeutic Protein Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share in Value by Type in 2022
Figure 17. Latin America Recombinant Therapeutic Protein Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Recombinant Therapeutic Protein Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Therapeutic Protein Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Therapeutic Protein Revenue in 2022
Figure 23. Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Medicine
Figure 25. Global Medicine Sales YoY Growth (2018-2034) & (MT)
Figure 26. Product Picture of Scientific Research
Figure 27. Global Scientific Research Sales YoY Growth (2018-2034) & (MT)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2018-2034) & (MT)
Figure 30. Global Recombinant Therapeutic Protein Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Recombinant Therapeutic Protein Sales Market Share by Application in 2022 & 2034
Figure 32. North America Recombinant Therapeutic Protein Sales Market Share in Volume by Application in 2022
Figure 33. North America Recombinant Therapeutic Protein Sales Market Share in Value by Application in 2022
Figure 34. Europe Recombinant Therapeutic Protein Sales Market Share in Volume by Application in 2022
Figure 35. Europe Recombinant Therapeutic Protein Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share in Value by Application in 2022
Figure 38. Latin America Recombinant Therapeutic Protein Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Recombinant Therapeutic Protein Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Recombinant Therapeutic Protein Manufacturing Cost Structure
Figure 43. Recombinant Therapeutic Protein Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed